$BBOT SEC Filings

Filed On	Filing
23 Oct 2026	Form 4: Cobo Marc, Principal Accounting Officer Gave up 203 shares to cover exercise price or tax ($544)
05 Oct 2026	Form 4: Cobo Marc, Principal Accounting Officer Gave up 126 shares to cover exercise price or tax ($496)
05 Oct 2026	Form 4: Elmelech Idan, COO & Principal Financial Ofcr Gave up 343 shares to cover exercise price or tax ($1.35K)
05 Oct 2026	Form 4: Beltran Pedro, Director Gave up 1,047 shares to cover exercise price or tax ($4.13K)
05 Oct 2026	Form 4: Ben Yong, Chief Med & Dev Officer Gave up 1,047 shares to cover exercise price or tax ($4.13K)
14 Sep 2026	Form 4: Cobo Marc, Principal Accounting Officer Received 9,038 shares as a grant or award · Gave up 203 shares to cover exercise price or tax ($1.12K) · Granted 43,700 Stock Option (Right to Buy)
10 Sep 2026	EFFECT
08 Sep 2026	EFFECT
08 Sep 2026	8-K: Other Events Corporate Update September 2026 BBOT Next-Generation RAS-Pathway Therapeutics
01 Sep 2026	S-3
01 Sep 2026	POS AM
12 Aug 2026	424B3
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
06 Jul 2026	Form 4: Ben Yong, Chief Med & Dev Officer Gave up 1,047 shares to cover exercise price or tax ($8.17K)
06 Jul 2026	SCHEDULE 13D/A
06 Jul 2026	Form 4: Chen Bihua, Director Disposed of 4,528,186 shares (Other Transaction) · Acquired 4,528,186 shares (Other Transaction)
06 Jul 2026	Form 4: Cobo Marc, Principal Accounting Officer Gave up 125 shares to cover exercise price or tax ($975)
06 Jul 2026	Form 4: Elmelech Idan, COO & Principal Financial Ofcr Gave up 343 shares to cover exercise price or tax ($2.68K)
06 Jul 2026	Form 4: Beltran Pedro, Director Gave up 1,047 shares to cover exercise price or tax ($8.17K)

Comments